Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Sasadeusz

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2020
Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up TrialJoseph S Doyle, Daniela K van Santen, David Iser, et al.
Internal Medicine Journal|November 22, 2025
Convalescent plasma in hospitalised patients with COVID-19Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence|February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Journal of Virology|May 22, 2009
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionJ Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2020
Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up TrialJoseph S Doyle, Daniela K van Santen, David Iser, et al.
Internal Medicine Journal|November 22, 2025
Convalescent plasma in hospitalised patients with COVID-19Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence|February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.
Pageof 7